Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Flunitrazepam and driving ability].

R M Kaufmann1, R Frey, H J Battista

  • 1Klinische Abteilung für Allgemeine Psychiatrie, Universitätsklinik für Psychiatrie, Wien. rainer.kaufmann@akhwien.at

Fortschritte Der Neurologie-Psychiatrie
|September 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GW170814: A Three-Detector Observation of Gravitational Waves from a Binary Black Hole Coalescence.

Physical review letters·2017
Same author

Acoustic structure of alarm calls in Indian sambar (Rusa unicolor) and Indian muntjac (Muntiacus vaginalis) in South Vietnam.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections·2017
Same author

GW170104: Observation of a 50-Solar-Mass Binary Black Hole Coalescence at Redshift 0.2.

Physical review letters·2017
Same author

Upper Limits on the Stochastic Gravitational-Wave Background from Advanced LIGO's First Observing Run.

Physical review letters·2017
Same author

Directional Limits on Persistent Gravitational Waves from Advanced LIGO's First Observing Run.

Physical review letters·2017
Same author

Prospects for Observing and Localizing Gravitational-Wave Transients with Advanced LIGO and Advanced Virgo.

Living reviews in relativity·2017
Same journal

[Rare hereditary and acquired diseases with parkinson's syndrome].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Dementia with Lewy bodies].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Impact of the PEPP reimbursement system and other developments on inpatient care of general psychiatry patients 2005 to 2022: a retrospective analysis].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[The pathology of the brain eating amoeba Naegleria fowleri].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Chronic vestibular syndromes: Correct diagnosis and treatment].

Fortschritte der Neurologie-Psychiatrie·2026
See all related articles

Flunitrazepam, a benzodiazepine, can impair driving ability. Research shows varied effects based on dosage and study design, necessitating careful evaluation of drug-driving risks.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Traffic Safety

Context:

  • Experimental and epidemiological studies investigate drug effects on driving.
  • Flunitrazepam, a benzodiazepine, is frequently linked to driving impairment.
  • Assessing drug risks requires comprehensive study analysis, not isolated findings.

Purpose:

  • To review published studies on flunitrazepam's influence on driving ability.
  • To highlight variations in dosages, experimental designs, and testing methods.
  • To analyze acute, residual, and subchronic effects of flunitrazepam on driving.

Summary:

  • Experimental studies are key to understanding drug impacts on driving.
  • Flunitrazepam's effects on driving vary significantly across studies.

Related Experiment Videos

  • Lack of standardization prevented a meta-analysis of flunitrazepam's driving risks.

    • Impact:

    • Informs on the complex relationship between benzodiazepines and driving safety.
    • Underscores the need for standardized research methodologies in psychopharmacology.
    • Provides a basis for understanding flunitrazepam's specific risks in traffic scenarios.